This educational activity is intended for an international audience of non-US hematology/oncology specialists, critical care specialists, and cardiologists.
The goal of this activity is to increase knowledge on the role of thrombosis and inflammation in patients with COVID-19 and implications to managing these patients, including those with cancer.
Upon completion of this activity, participants will:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 11/13/2020
Valid for credit through: 11/13/2021, 11:59 PM EST
processing....
ACE = angiotensin-converting enzyme
aPTT = activated partial thromboplastin time
AUC = area under the curve
bid = twice daily
BMI = body mass index
CI = confidence interval
CV = cardiovascular
DIC = disseminated intravascular coagulation
DOAC = direct oral anticoagulant
DVT = deep vein thrombosis
EC = endothelial cell
ECMO = extracorporeal membrane oxygenation
F = factor
G-CSF = granulocyte colony-stimulating factor
HR = hazard ratio
ICU = intensive care unit
IFN = interferon
IL = interleukin
Hs-cTnI = high-sensitivity cardiac troponin
LMWH = low-molecular-weight heparin
MCP1 = monocyte chemoattractant protein-1
OR = odds ratio
PaO2/FiO2 = ratio of arterial partial pressure of oxygen to fraction of inspired oxygen
PAI = plasminogen activator inhibitor
PCR = polymerase chain reaction
PIC = pulmonary intravascular coagulation
po = by mouth
PT = prothrombin time
qd = once daily
ROC = receiver operating characteristics
RV = right ventricular
SpO2 = saturation of oxygen
sq = subcutaneous
tid = three times daily
TF = tissue factor
TM = thrombomodulin
TNF = tumor necrosis factor
tPA = tissue plasminogen activator
UFH = unfractionated heparin
uPA = urokinase-type plasminogen activator
uPAR = urokinase-type plasminogen activator receptor
VEGF = vascular endothelial growth factor
VTE = venous thromboembolism
« Return to: COVID 19, thrombosis, inflammation and cancer: Lessons Learned and Future Practice |